Page last updated: 2024-10-19

phenol and Cerebral Palsy

phenol has been researched along with Cerebral Palsy in 7 studies

Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)

Research Excerpts

ExcerptRelevanceReference
"To compare the treatment effectiveness of botulinum toxin type A (BTX-A) and phenol blocks in managing lower limb spasticity and gait dysfunction in children with cerebral palsy."7.72Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy. ( Chen, CL; Chen, CP; Chen, MJ; Chou, SW; Chung, CY; Wong, AM, 2004)
"To investigate the safety of single and repeated multilevel injections of botulinum toxin (BoNT) alone or a combination of phenol and BoNT performed under general anesthesia in children with chronic muscle spasticity."3.74Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population. ( Ajizian, SJ; Kolaski, K; Koman, LA; Passmore, L; Pasutharnchat, N; Smith, BP, 2008)
"To compare the treatment effectiveness of botulinum toxin type A (BTX-A) and phenol blocks in managing lower limb spasticity and gait dysfunction in children with cerebral palsy."3.72Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy. ( Chen, CL; Chen, CP; Chen, MJ; Chou, SW; Chung, CY; Wong, AM, 2004)
"To describe the specific techniques and adverse reactions of using concurrent, multiple injections of both botulinum toxin and phenol to manage spasticity in children with cerebral palsy (CP) and other neurologic conditions."3.72Combining botulinum toxin and phenol to manage spasticity in children. ( Gooch, JL; Patton, CP, 2004)
"While in some children, spasticity may adversely impact the motor abilities, in others, it may help maintain posture and ability to ambulate."2.43Pharmacologic interventions for reducing spasticity in cerebral palsy. ( Patel, DR; Soyode, O, 2005)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (85.71)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ploypetch, T1
Kwon, JY1
Armstrong, HF1
Kim, H1
Kolaski, K1
Ajizian, SJ1
Passmore, L1
Pasutharnchat, N1
Koman, LA1
Smith, BP1
Wong, AM1
Chen, CL1
Chen, CP1
Chou, SW1
Chung, CY1
Chen, MJ1
Gooch, JL1
Patton, CP1
Patel, DR1
Soyode, O1
Tilton, AH1
Goldstein, EM1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Clinical Effect and Sonographic Findings of Kinesiotaping Combined With Therapeutic Exercise in Upper Extremity Spasticity and Function in Subacute Stroke Patients[NCT03024190]36 participants (Actual)Interventional2017-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for phenol and Cerebral Palsy

ArticleYear
Pharmacologic interventions for reducing spasticity in cerebral palsy.
    Indian journal of pediatrics, 2005, Volume: 72, Issue:10

    Topics: Administration, Oral; Adrenergic alpha-Agonists; Age Factors; Anti-Infective Agents, Local; Baclofen

2005
Therapeutic interventions for tone abnormalities in cerebral palsy.
    NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics, 2006, Volume: 3, Issue:2

    Topics: Administration, Oral; Anti-Dyskinesia Agents; Baclofen; Botulinum Toxins; Cerebral Palsy; Humans; Mu

2006
Spasticity management: an overview.
    Journal of child neurology, 2001, Volume: 16, Issue:1

    Topics: Anti-Dyskinesia Agents; Baclofen; Botulinum Toxins; Cerebral Palsy; Child, Preschool; Exercise; GABA

2001

Other Studies

4 other studies available for phenol and Cerebral Palsy

ArticleYear
A Retrospective Review of Unintended Effects After Single-Event Multi-Level Chemoneurolysis With Botulinum Toxin-A and Phenol in Children With Cerebral Palsy.
    PM & R : the journal of injury, function, and rehabilitation, 2015, Volume: 7, Issue:10

    Topics: Botulinum Toxins, Type A; Cerebral Palsy; Child; Child, Preschool; Female; Humans; Male; Muscle Spas

2015
Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population.
    American journal of physical medicine & rehabilitation, 2008, Volume: 87, Issue:7

    Topics: Age Factors; Anti-Dyskinesia Agents; Anti-Infective Agents, Local; Botulinum Toxins; Cerebral Palsy;

2008
Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy.
    American journal of physical medicine & rehabilitation, 2004, Volume: 83, Issue:4

    Topics: Botulinum Toxins, Type A; Case-Control Studies; Cerebral Palsy; Child; Child, Preschool; Electromyog

2004
Combining botulinum toxin and phenol to manage spasticity in children.
    Archives of physical medicine and rehabilitation, 2004, Volume: 85, Issue:7

    Topics: Adolescent; Botulinum Toxins, Type A; Cerebral Palsy; Child; Child, Preschool; Drug Therapy, Combina

2004